Anti-SSA Ro autoantibodies
Results: 80
# | Item |
---|---|
1![]() | arGEN-X raises EUR 5 million from PMV in extension of EUR 32.5 million series B Funds to advance ARGX-113, a novel antibody fragment approach to promote degradation and clearance of disease-causing autoantibodies, towardAdd to Reading ListSource URL: www.biogenerationventures.comLanguage: English - Date: 2013-11-04 05:32:28 |
2![]() |